BIOMARKER:

EGFR G719S

Entrez ID:

Related biomarkers:

‹

›

EGFR G719S EGFR G719S	Non Small Cell Lung Cancer NSCLC	EGFR G719S EGFR G719S	Non Small Cell Lung Cancer NSCLC	gefitinib Sensitive: B - Late Trials	gefitinib Sensitive: B - Late Trials
EGFR G719S EGFR G719S	Non Small Cell Lung Cancer NSCLC	EGFR G719S EGFR G719S	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C2 – Inclusion Criteria	erlotinib Sensitive: C2 – Inclusion Criteria
EGFR G719S EGFR G719S	Non Small Cell Lung Cancer NSCLC	EGFR G719S EGFR G719S	Non Small Cell Lung Cancer NSCLC	osimertinib Sensitive: C3 – Early Trials	osimertinib Sensitive: C3 – Early Trials
EGFR G719S EGFR G719S	Lung Adenocarcinoma LUAD	EGFR G719S EGFR G719S	Lung Adenocarcinoma LUAD	erlotinib Sensitive: C4 – Case Studies	erlotinib Sensitive: C4 – Case Studies
EGFR G719S EGFR G719S	Colon Cancer Colon Cancer	EGFR G719S EGFR G719S	Colon Cancer Colon Cancer	ABP 494 (cetuximab biosimilar) Sensitive: D – Preclinical	ABP 494 (cetuximab biosimilar) Sensitive: D – Preclinical
EGFR G719S EGFR G719S	Colon Cancer Colon Cancer	EGFR G719S EGFR G719S	Colon Cancer Colon Cancer	cetuximab Sensitive: D – Preclinical	cetuximab Sensitive: D – Preclinical
EGFR G719S EGFR G719S	Colon Cancer Colon Cancer	EGFR G719S EGFR G719S	Colon Cancer Colon Cancer	panitumumab Sensitive: D – Preclinical	panitumumab Sensitive: D – Preclinical